‘Chinese Peptides’ Are the Latest Biohacking Trend in the Tech Worldnews2026-01-03T05:00:14+00:00January 3rd, 2026|The New York Times|
F.D.A. Approves Wegovy Weight-Loss Pillnews2025-12-23T14:37:51+00:00December 23rd, 2025|The New York Times|
Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?news2025-12-02T10:04:46+00:00December 2nd, 2025|The New York Times|
U.S. Announces Negotiated Prices for 15 Drugs Under Medicarenews2025-11-26T03:09:55+00:00November 26th, 2025|The New York Times|
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Findsnews2025-11-25T20:54:17+00:00November 25th, 2025|The New York Times|
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Valuenews2025-11-21T21:25:40+00:00November 21st, 2025|The New York Times|
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
What Is Kennedy’s Problem With Medication?news2025-11-11T02:01:21+00:00November 11th, 2025|The New York Times|
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
